MedPath

Cost-effectiveness of Venous Thromboembolism Prophylaxis Protocol Implementation Compared to Routine clinical Practice in a Tertiary Hospital in Thailand

Completed
Conditions
The use of thromboprophylaxis has led to significant reductions in VTE and PE incidences. There is a lack of cost-effectiveness evidence of the implementation of a VTE prophylaxis protocol in Thailand.
VTE, prophylaxis, cost-effective
Registration Number
TCTR20231101006
Lead Sponsor
Mahidol University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
4579
Inclusion Criteria

1. The patients admitted to the surgical department
2. Age > 15 years

Exclusion Criteria

1. The patients who had previously undergone VTE diagnosis and treatment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cost-effectiveness ratio (ICER), 1 year the cost per QALY gained
Secondary Outcome Measures
NameTimeMethod
probabilistic sensitivity analysis (PSA) 1 year the likelihood of intervention cost-effectiveness across various willingness-to-pay thresholds.
© Copyright 2025. All Rights Reserved by MedPath